Luca Luigi Polastri serves as the Global Director - Value and Access Head for the Nephrology Franchise at Kyowa Kirin International plc, where he plays a pivotal role in shaping the market access strategy and pricing framework for innovative therapies in the nephrology sector. With...
Luca Luigi Polastri serves as the Global Director - Value and Access Head for the Nephrology Franchise at Kyowa Kirin International plc, where he plays a pivotal role in shaping the market access strategy and pricing framework for innovative therapies in the nephrology sector. With extensive experience in market access and public affairs, Luca has developed a profound understanding of both national and regional health systems, particularly within Italy. His expertise in tender management processes has been instrumental in navigating complex reimbursement landscapes, ensuring that new therapies reach patients effectively and efficiently.
In his current role, Luca leads key projects aimed at optimizing the launch and market positioning of nephrology products, leveraging his proven track record in positive reimbursement outcomes. His strategic vision encompasses the definition and implementation of comprehensive market access plans that align with the evolving needs of healthcare stakeholders. By fostering strong relationships with public health authorities and engaging in proactive dialogue, he ensures that Kyowa Kirin's innovative solutions are recognized for their value in improving patient outcomes.
Luca's skill set extends across various therapeutic areas, including gastroenterology and psychiatry, allowing him to bring a multifaceted approach to market access challenges. His leadership in product launches and sales management is complemented by a deep commitment to advancing public health initiatives. As the nephrology landscape continues to evolve, Luca Luigi Polastri remains at the forefront, driving initiatives that not only enhance access to essential therapies but also contribute to the broader goals of healthcare equity and patient-centered care.
